Taking Control of Your Diabetes (TCOYD) Making the Connection (MTC) Virtual Conference is organized by Taking Control of Your Diabetes (TCOYD) and will be held on Dec 12, 2020.
Accreditation:
AMA: The University of California, San Diego School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants: The AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 6.0 hours of Category 1 credit for completing this program.
Pharmacist Accreditation Statement:
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation:
Global Education Group designates this continuing education activity for 6.0 contact hour(s) (0.6 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – 0530-9999-20-092-L01-P)
Description:
An immersive, interactive LIVE CME conference experience for Healthcare Professionals FROM AROUND THE WORLD…with additional speakers, varied on-demand lectures and even more opportunities for networking and Q&A!
They are bringing you a one-of-a-kind virtual educational experience where you can feel the excitement and interactivity of an in-person event from the comfort of your own home. Take part in discussions on the most ground-breaking topics in treating type 1 and type 2 diabetes to open two-communication with your patients and improve long-term outcomes-presented by our world-renowned speakers with real experience (many who live with diabetes themselves)! Don’t forget to interact with our cutting-edge exhibitors and network with our worldwide community of healthcare professionals.
*There is always more to learn-on-demand lectures vary for every MTC Virtual PLUS Event so no two will ever be the same.
What you will learn:
We focus on four distinct areas of the most cutting-edge diabetes management strategies:
• Patient-provider relationships with a focus on communication methods to improve adherence and persistence
• Oral agents for the treatment of type 2 diabetes and their effect on cardiovascular health
• Injectable therapies, including insulin, for use in patients with type 2 diabetes and their cardiovascular impact
• Time in range and the unmet needs of type 1 diabetes
Learning Objectives:
At course completion, participants should be able to:
• Identify the different pathophysiologic defects associated with type 2 diabetes and how all the pharmacologic agents (oral and injectable) address these specific abnormalities.
• Develop individualized treatment strategies based on the living standards of care and patient characteristics.
• Discuss the recently published cardiovascular-renal outcome trials on oral and injectable type 2 medications.
• Summarize the most up-to-date clinical information on GLP-1 RA and SGLT-2 inhibitors.
• Evaluate the use of SGLT-2 and GLP-1 RA in patients who have cardiovascular risks factors and are at risk or have a history of atherosclerotic cardiovascular disease (ASCVD).
• Discuss approaches to combination therapy with the currently available oral agents, as well as physician and patient-directed insulin titration strategies and the basal-bolus approach.
• Design a treatment plan for multiple daily injection regimens and insulin pump therapy.
• Explain how to interpret continuous glucose monitoring (CGM) data.
• Demonstrate the ability to select effective therapeutic adjustments based on CGM trending or rate of change arrows, time in range, and standard deviation.
• Recognize the physical and emotional barriers that prevent patients with diabetes from being persistent and adherent to their therapeutic regimen(s).
• Employ innovative and dynamic strategies for communication with patients to strengthen provider-patient relations and improve patient outcomes.
